Results 1 to 10 of about 6,974,500 (303)

Life's Essential 8 and Risk of Severe COVID‐19 Among Adults Without Clinical Cardiovascular Disease: The C4R Study [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Cardiovascular disease is a risk factor for severe COVID‐19 (ie, hospitalization or death). Whether better cardiovascular health (CVH) is associated with lower risk of severe COVID‐19 among adults without cardiovascular disease is unknown.
Timothy B. Plante, Yifei Sun, Pallavi P. Balte, Donald Lloyd‐Jones, Hongyan Ning, Norrina Allen, Morgana Mongraw‐Chaffin, Kelley Pettee Gabriel, Vanessa Xanthakis, Arnita F. Norwood, Sara Gonzalez, Daniela Sotres‐Alvarez, Gregory A. Talavera, Martha L. Daviglus, Sameera A. Talegawkar, Namratha Kandula, Mitchell S. V. Elkind, Tatjana Rundek, Jose Gutierrez, Emily B. Levitan, Mary Cushman, Suzanne E. Judd, Henry E. Wang, Neil A. Zakai, Virginia J. Howard, Nathalie Pamir, Monika M. Safford, Debora Kamin Mukaz, Amanda M. Fretts, Stephen P. Juraschek, Elizabeth C. Oelsner   +30 more
doaj   +2 more sources

COVID‐associated arthritis after severe and non‐severe COVID‐19: A systematic review

Immunity, Inflammation and Disease, 2023
Aim Since the coronavirus outbreak became a global health emergency in 2020, various immune‐based effects, such as inflammatory arthritis (IA), have been recorded.
Mahsa Zarpoosh, Parsa Amirian
doaj   +1 more source

Acute haemorrhagic leukoencephalitis (Hurst disease) in severe COVID- 19 infection

Brain, Behavior, & Immunity - Health, 2021
Coronavirus Disease 2019 (COVID-19) is well documented as a cause of respiratory tract infection. Increasingly, multi-systemic effects, including COVID-19-related neurologic features, are being reported.
Ala Haqiqi, Theophilus Luke Samuels, Fiona Jillian Lamb, Tamir Moharrum, Alice Elizabeth Myers   +4 more
doaj   +1 more source

Severe loss of mechanical efficiency in COVID‐19 patients

Journal of Cachexia, Sarcopenia and Muscle, 2021
Background There is limited information about the impact of coronavirus disease (COVID‐19) on the muscular dysfunction, despite the generalized weakness and fatigue that patients report after overcoming the acute phase of the infection.
Eulogio Pleguezuelos, Amin Del Carmen, Gemma Llorensi, Jessica Carcole, Paula Casarramona, Eva Moreno, Pilar Ortega, Mateo Serra‐Prat, Elisabet Palomera, Marc M. Miravitlles, Joan Carles Yebenes, Ramón Boixeda, Lluis Campins, Koldo Villelabeitia‐Jaureguizar, Manuel Vicente Garnacho‐Castaño   +14 more
doaj   +1 more source

Severe oropharyngeal dysphagia following COVID‐19: a case report

Clinical Case Reports, 2021
Dysphagia may occur after a prolonged intubation due to COVID‐19 but it is usually mild. Case reports on severe dysphagia following COVID‐19 are infrequent.
Giulia De Vincentis, Chiara Ferrari, Dario Guerini Rocco   +2 more
doaj   +1 more source

Severe superior mesenteric vein thrombosis after COVID‐19 mRNA vaccination

Clinical Case Reports, 2023
Key Clinical Message Venous thrombosis is a rare occurrence following the administration of the COVID‐19 mRNA vaccine. The occurrence of superior mesenteric vein (SMV) is even more rare.
Takahiro Kubo, Hideto Kawaratani, Hitoshi Yoshiji   +2 more
doaj   +1 more source

Efficacy of canakinumab in mild or severe COVID‐19 pneumonia

Immunity, Inflammation and Disease, 2021
Background Clinicians all around the world are currently experiencing a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Several therapeutic strategies have been used until now but, to date, there is no specific therapy to
Katia Falasca, Myriam Di Penta, Claudio Ucciferri, Antonio Auricchio, Marta Di Nicola, Michele Marchioni, Eleonora Celletti, Emanuela Sabatini, Francesco Cipollone, Jacopo Vecchiet   +9 more
doaj   +1 more source

Can COVID‐19 cause severe neutropenia?

Clinical Case Reports, 2020
This is the first case of acquired severe neutropenia in the context of COVID‐19 reported to date. This could illustrate another less frequent hematological disorder related to this novel viral infection.
Patricia López‐Pereira, Isabel Iturrate, Rafael de La Cámara, Laura Cardeñoso, Adrián Alegre, Beatriz Aguado   +5 more
doaj   +1 more source

Severe COVID‐19 during pregnancy in Sweden, Norway, and Denmark

Acta Obstetricia et Gynecologica Scandinavica, 2023
Introduction Pregnancy is a risk factor for severe coronavirus disease 2019 (COVID‐19) and adverse pregnancy outcomes. We aimed to explore maternal characteristics, pregnancy outcomes, vaccination status, and virus variants among pregnant women admitted ...
Anne K. Örtqvist, Maria C. Magnus, Anna J. M. Aabakke, Stine Kjaer Urhoj, Anne Vinkel Hansen, Anne‐Marie Nybo Andersen, Lone Krebs, Karin Pettersson, Siri E. Håberg, Olof Stephansson   +9 more
doaj   +1 more source

Diaphragm dysfunction in severe COVID‐19 as determined by neuromuscular ultrasound

Annals of Clinical and Translational Neurology, 2021
Many survivors from severe coronavirus disease 2019 (COVID‐19) suffer from persistent dyspnea and fatigue long after resolution of the active infection. In a cohort of 21 consecutive severe post‐COVID‐19 survivors admitted to an inpatient rehabilitation ...
Ellen Farr, Alexis R. Wolfe, Swati Deshmukh, Leslie Rydberg, Rachna Soriano, James M. Walter, Andrea J. Boon, Lisa F. Wolfe, Colin K. Franz   +8 more
doaj   +1 more source